Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. - Wikidata - awgldk - TriplyDB

Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.

Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.

http://www.wikidata.org/entity/Q34984061

about

Molecular underpinnings of corneal angiogenesis: advances over the past decade Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)Intravital two-photon microscopy of immune cell dynamics in corneal lymphatic vessels Horizons in therapy for corneal angiogenesis.SLURP-1 modulates corneal homeostasis by serving as a soluble scavenger of urokinase-type plasminogen activator Neostatin-7 regulates bFGF-induced corneal lymphangiogenesis Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury.'Chimeric' grafts assembled from multiple allodisparate donors enjoy enhanced transplant survival.Klf4 regulates the expression of Slurp1, which functions as an immunomodulatory peptide in the mouse cornea.Vascular endothelial growth factor-D over-expressing tumor cells induce differential effects on uterine vasculature in a mouse model of endometrial cancer NGF and NGF-receptor expression of cultured immortalized human corneal endothelial cells The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation Corneal transplantation and immune privilege.Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival.Dry eye as a mucosal autoimmune disease.Selective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesis Corneal lymphangiogenesis in herpetic stromal keratitis IL-17 and VEGF are necessary for efficient corneal nerve regeneration.A novel function for programmed death ligand-1 regulation of angiogenesis Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.High-risk corneal allografts and why they lose their immune privilege.VIP and growth factors in the infected cornea.Comparison of galectin expression signatures in rejected and accepted murine corneal allografts.Pharmacologic uncoupling of angiogenesis and inflammation during initiation of pathological corneal neovascularization Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease The Naïve Murine Cornea as a Model System to Identify Novel Endogenous Regulators of Lymphangiogenesis: TRAIL and rtPA.Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis.Efficacy of topical blockade of interleukin-1 in experimental dry eye disease MicroRNA-31 targets FIH-1 to positively regulate corneal epithelial glycogen metabolism.Corneal Expression of SLURP-1 by Age, Sex, Genetic Strain, and Ocular Surface Health.VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes Influence of timing (pre-puberty or skeletal maturity) of ovariohysterectomy on mRNA levels in corneal tissues of female rabbits Nerves and neovessels inhibit each other in the cornea.Autoimmunity at the ocular surface: pathogenesis and regulation.Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity.Maintaining transparency: a review of the developmental physiology and pathophysiology of two avascular tissues VEGF Trap(R1R2) suppresses experimental corneal angiogenesis.Vascular endothelial growth factor mediates corneal nerve repair.

P2860

Q26747539-ACE03B3B-ACFB-4DA9-B4B1-72F5A66AC77E Q26823757-34D5EB05-43EC-4A4D-B471-DF2C9E51EC55 Q27316545-068BFDFE-1D59-42EF-BC22-F3423D294FF3 Q27691454-555B7DA7-95B4-4185-B759-C8D3C24D73C0 Q28115141-478B5C6D-1BAB-45A4-9F37-98812F5A54FB Q33345623-0BFD2087-8D5D-4D41-89E3-D6064BF641E3 Q33556241-895F2CF7-656A-4AC4-8CB5-2267CBA4E658 Q33731085-90C72E97-9E85-4745-8032-08E849CC61E5 Q33961178-4548B17E-25C7-4E56-8C56-52A654AEEC8E Q34016911-864F2F7D-BE65-449D-8B24-5A307F01BCEE Q34032494-F487A742-4A72-44FC-8C3E-CCB52AA821A2 Q34230865-749029EA-140D-4009-BCEA-D9A7961F986A Q34325061-D55B56B4-063D-4032-BBAF-9619496BEAD2 Q34459026-8A1CF336-E5D3-4280-B791-B556329E8E6D Q34647761-323A726C-73C4-4DDC-BD4F-007C602C6D8E Q34662175-0500DDBE-A50E-4FE5-8353-F6C061BF8AC3 Q34674612-5E4F7526-144E-4951-A439-E1A4D1A0EC7C Q34755584-25924C16-D0A8-4215-81A4-46AD8B460579 Q34805624-4885D17B-7781-4D46-B99A-AA23686D68D1 Q34973731-664F037A-49ED-4E60-AAAD-1B2E01BEF589 Q35048752-05259C43-6089-4F15-8934-0E99CE714867 Q35221183-DB0DF21A-85A3-4EE3-8ED8-E8039371AF12 Q35602405-0A582F8E-5B96-414C-AB56-F95A94DC9B0D Q35639944-DE01B417-64F8-4935-A702-F0E1AC369734 Q35672575-437B86A3-9DD2-4D15-8C37-BBB8906F6DAC Q35822076-64D6D90A-2C62-451D-9848-00ED203FE57B Q35907009-252E406C-DC98-4548-9C97-0FDF98242602 Q35921437-87897EE6-E445-4F2F-8325-43DB02AC6FA4 Q36044544-2CF9E28F-045A-4A71-9A38-B0D284696455 Q36117443-F9DD5C17-3F85-43FE-852C-7BABF44274E5 Q36380577-092629C5-6178-4F2A-9F7F-EFDC3B967B34 Q36384880-3C2C82EE-BEE9-434F-8159-C378984261AF Q36498999-0919E803-A1A7-4817-9363-1C8B1CFC058B Q36581261-FF50EE8F-2CC6-4E0F-9F94-AF39740FB601 Q36625074-9D631069-CE20-4E36-8E37-1136B883CA6A Q36808641-6260D109-FCD5-4C5A-B164-F350D31149D5 Q36850869-801C84B2-DDAD-4F6A-B1BD-4D01AFA40D43 Q36963548-9A428B98-69D7-4C36-804A-2125EEA04F82 Q37004659-A732556C-F627-4B71-8A89-7DFAD35A86F1 Q37051762-4B68EDF9-0966-4EF3-8259-DE64088C4EE1

P2860

Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.

http://www.wikidata.org/entity/Q34984061

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Nonvascular VEGF receptor 3 ex ...... tains avascularity and vision.

@ast

Nonvascular VEGF receptor 3 ex ...... tains avascularity and vision.

@en

Nonvascular VEGF receptor 3 ex ...... tains avascularity and vision.

@nl

type

label

Nonvascular VEGF receptor 3 ex ...... tains avascularity and vision.

@ast

Nonvascular VEGF receptor 3 ex ...... tains avascularity and vision.

@en

Nonvascular VEGF receptor 3 ex ...... tains avascularity and vision.

@nl

prefLabel

Nonvascular VEGF receptor 3 ex ...... tains avascularity and vision.

@ast

Nonvascular VEGF receptor 3 ex ...... tains avascularity and vision.

@en

Nonvascular VEGF receptor 3 ex ...... tains avascularity and vision.

@nl

P1433

Q34984061-515936C5-92F2-401A-9F7B-41E69DAC0B8E

P1476

Q34984061-364B44F4-1FFA-468B-867C-9C1A69A24631

P2093

Q34984061-19ACEDD0-00B1-4BDF-8259-149A05C7B122

Q34984061-333BF83D-9E2F-4911-9B63-8B1367A131DA

Q34984061-47030066-7481-4600-90FC-9F2EECE0C77B

Q34984061-57C02D03-6847-4E60-8309-45EC686478FF

Q34984061-610605D0-63A9-4064-B01F-FEDB5A6F6597

Q34984061-71A7FB05-5728-4534-88AA-7530E5D213D2

Q34984061-A791D286-19D0-4E7F-A4CF-4FE4201FB2A7

Q34984061-AE3693C4-E416-4120-BC33-146DD4B8A66B

Q34984061-BACF2621-1CCE-43C8-AE34-4C0FECA3DB7C

Q34984061-C74883E9-6FCB-4011-8ED4-7795D390E633

P2860

Q34984061-0163C4FC-087C-4602-A10B-E6BDE2479452

Q34984061-20B24319-3D17-44B6-9FAE-5E79C11245F2

Q34984061-2690054E-E413-41A2-B4D8-BE8D2E19D50D

Q34984061-26976B49-A993-4BA6-B3B7-469C66279C3C

Q34984061-28C4D4A6-A0E9-4BFE-81C9-7053609241CF

Q34984061-29AFF0B8-F2DD-4B66-8D19-EDC54D39AA21

Q34984061-3CD10E85-5BA2-45AC-9DA9-9FA5DE8A969F

Q34984061-3E9FDFFE-8321-4097-BC16-D4C713DBF517

Q34984061-46511456-0EC7-4E58-845E-FFA579CB6F81

Q34984061-4CF8A63B-50B7-4867-A728-ED04B233CA6D

P304

Q34984061-570DC381-061B-45D6-AAB2-F35339487E8E

P31

Q34984061-94261A1E-0DA3-4999-B345-DDA1C4EF511A

P356

Q34984061-57D3CDA7-D743-43D8-966D-BD9E1BF61C53

P407

Q34984061-64EEC300-EFEB-4712-87A3-EB6831BD7A38

P433

Q34984061-7295E8F8-001F-4978-B9E7-62FB0D0B5010

P478

Q34984061-A8591148-4040-46E7-B486-C947D1B46DC2

P50

Q34984061-987DA6E5-B1A4-49A7-91E8-BBB613CE82FD

P577

Q34984061-5E5C1FA2-00C5-4688-B73B-F17DA0CA6E6C

P5875

Q34984061-E79F722F-4192-469F-AD28-047BEF4B0BE7

P698

Q34984061-4DB07EFE-C4A9-4953-ABF5-CD9F0FB18853

P921

Q34984061-00228A15-AB4F-4570-8ECB-66FBA033951D

Q34984061-892C4312-3357-4C64-AAD7-9E12AA7AE5E3

P932

Q34984061-36E2AADD-A7DB-4EF2-85CC-3917845DE664

P356

PNAS.0506112103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Nonvascular VEGF receptor 3 ex ...... tains avascularity and vision.

@en

P2093

Bronislaw Pytowski

http://www.w3.org/2001/XMLSchema#string

J Wayne Streilein

http://www.w3.org/2001/XMLSchema#string

Kris Persaud

http://www.w3.org/2001/XMLSchema#string

Lu Chen

http://www.w3.org/2001/XMLSchema#string

Magali Saint-Geniez

http://www.w3.org/2001/XMLSchema#string

Pedram Hamrah

http://www.w3.org/2001/XMLSchema#string

Reza Dana

http://www.w3.org/2001/XMLSchema#string

Saadia Rashid

http://www.w3.org/2001/XMLSchema#string

Yan Wu

http://www.w3.org/2001/XMLSchema#string

Yiping Jin

http://www.w3.org/2001/XMLSchema#string

P2860

VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses

Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C

FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines.

Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice.

Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.

Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.

Novel production of interleukin-1 receptor antagonist peptides in normal human cornea.

Ocular immune privilege: therapeutic opportunities from an experiment of nature.

Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization.

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

P304

11405-11410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0506112103

http://www.w3.org/2001/XMLSchema#string

P407

P433

30

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Claus Cursiefen

P577

2006-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6937265

http://www.w3.org/2001/XMLSchema#string

P698

16849433

http://www.w3.org/2001/XMLSchema#string

P921

avascular cornea development in camera-type eye

negative regulation of vasculature development involved in avascular cornea development in camera-type eye

P932

1544098

http://www.w3.org/2001/XMLSchema#string